About Us


Our Company

At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options. We apply our experience and unique insight into the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.

While others walk away from neuroscience because of risk and complexity, our team persists, resulting in four FDA-approved therapies for tardive dyskinesia, Parkinson’s disease, endometriosis*, and uterine fibroids*, as well as clinical programs in multiple therapeutic areas.

For three decades, Neurocrine Biosciences has applied its unique insights into neuroscience to advance medicines for neurological, endocrine, and psychiatric disorders. We have specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. Through internal investment and external collaboration, we relentlessly pursue scientific discovery and development that can lead to important therapies for patients who desperately need new, better options.

*in collaboration with AbbVie

Neurocrine Biosciences Corporate Information

The Company’s common stock is traded on the Nasdaq Global Select Market System under the symbol “NBIX”

Contact Information
Investor Relations
Telephone: (858) 617-7600

Neurocrine Biosciences
12780 El Camino Real
San Diego, CA 92130
Telephone: (858) 617-7600
Fax: (858) 617-7602


Our employees are our most valuable assets. No matter an individual’s role, level, or time with Neurocrine Biosciences, each person plays an important part in not only making a difference for patients, but also creating a great place to work.

Learn More

Our culture emphasizes collaboration and innovation as core values. Neurocrine Biosciences thrives as a company when we embrace unique ideas and a range of perspectives.

Learn More